GS Medical Co., Ltd. appears in FDA 510(k) records as the applicant for spinal hardware with the Orthopedic review-panel designation. The filings list Korean applicant addresses using the city forms Cheongju-Si and Cheongju, which is a filing address rather than a verified corporate headquarters. Two clearances are documented: the AnyPlus II Spinal Fixation System under product code NKB and The VEGA Cervical Screw System under product code NKG. Both are Class II devices, and both decisions are Substantially Equivalent. The record set is small, so the profile below describes what the filings show rather than the scope of the company's business. [1][2][4]
AnyPlus II Spinal Fixation System
K261217 covers the AnyPlus II Spinal Fixation System, cleared on October 2, 2026, with a receipt date of April 14, 2026. The product code is NKB, the regulation is 21 CFR 888.3070 for a Thoracolumbosacral Pedicle Screw System, and the device class is II. The decision code is SESE, described as Substantially Equivalent, and the clearance type is Special. The submission includes a summary, and the third-party review flag is No. [1]
The same device name appears in an earlier filing, K240350, where the trade name is given as AnyPlus II Spinal Fixation System under regulation 21 CFR 888.3070, Class II, with product codes NKB, KWP and KWQ. That letter states the device was determined substantially equivalent for indications for use, materials, performance, sterility and biocompatibility. The K240350 letter is addressed to a regulatory consultant on the applicant's behalf. [5]
A separate AccessGUDID record lists the AnyPlus II Spinal Fixation System under a device identifier and gives a customer contact phone number and email address associated with the gsmedi.com domain. That record is a labeling and identification entry, not a clearance document. [6]
The VEGA Cervical Screw System
K254260 covers The VEGA Cervical Screw System, cleared on September 17, 2026, with a receipt date of December 29, 2025. The product code is NKG, the regulation is 21 CFR 888.3075 for a Posterior Cervical Screw System, and the device class is II. The decision code is SESE, described as Substantially Equivalent, and the clearance type is Traditional. The submission includes a summary, and the third-party review flag is No. [2]
The FDA premarket notification page for K254260 lists the review panel as Orthopedic, the summary as available, the type as Traditional, third-party review as No, combination product as No, and a predetermined change control plan as not authorized. The page carries a last-updated date of November 9, 2026. [4]
Applicant identity and brand context
Both 510(k) records name GS Medical Co., Ltd. as the applicant and list postal code 28161 and country code KR. The K254260 record gives the city as Cheongju, while the other record uses Cheongju-Si. Each names a different individual contact. These are the applicant details recorded in the filings; they do not establish ownership, corporate structure or a headquarters location. [1][2]
A separate website, GS Medical USA, presents a product menu that includes the AnyPlus ACIF System, the GSS Pedicle Screw System, the Quasar cervical systems, the Pulsar Expandable System and the Tracker Plus Kyphoplasty System, and lists its own contact phone number and inquiry email address. The relationship between that site's operator and the FDA applicant is not stated in the public information, so the brand should not be treated as a verified parent or affiliate of GS Medical Co., Ltd. [8]
What the filing record shows
The supplied portfolio snapshot, retrieved November 20, 2026, contains two linked 510(k) records, both under the 510(k) pathway and both with a SESE decision. The decision counts for the full collection show two SESE decisions, and the explicitly smaller record sample of two entries shows the same two SESE decisions. These are counts of supplied filings as of that date, not measures of total portfolio size, sales or safety performance. [1][2]
Both documented devices are Class II orthopedic spinal systems with summaries on file and no third-party review. One was cleared under the Special program and the other under the Traditional route. No recall records appear in the supplied sample. [1][2][4]

